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access article under the CC BY-NC-NDSummary Osteoarticular tuberculosis constitutes about 3% of all tuberculosis cases. Early
and accurate diagnosis of tuberculosis is a challenging problem especially in the case of os-
teoarticular tuberculosis owing to the lower number of bacilli. However, an accurate and
timely diagnosis of the disease results in an improved efficacy of the given treatment. Besides
the limitations of conventional methods, nowadays molecular diagnostic techniques have
emerged as a major breakthrough for the early diagnosis of tuberculosis with high sensitivity
and specificity. Alpha-crystallin is a dominantly expressed protein responsible for the long
viability of the pathogen during the latent phase under certain stress conditions such as hyp-
oxia and nitric oxide stress. Two other proteinsdearly secreted antigenic target-6 and culture
filtrate protein-10dshow high expression in the active infective phase of Mycobacterium
tuberculosis. In this article, we focus on the different proteins expressed dominantly in
latent/active tuberculosis, and which may be further used as prognostic biomarkers for diag-
nosing tuberculosis, both in latent and active phases.
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According to World Health Organization (WHO) statistics for
2013, India has the highest burden of tuberculosis (TB),
with an estimated occurrence ofw2.1 million TB cases out
of the global total of 9 million cases. The approximate
figure for TB widespread for 2013 is given as 2.6 million [1],
of which 1e3% have osteoarticular involvement (Figure 1).
The incidence of TB is increasing, and skeletal or osteo-
articular TB accounts for 10e20% of all extrapulmonary
cases [2]. When TB affects a patient’s skeleton, it means
that the joints are involved, too. Although osteoarticular TB
most commonly occurs in the vertebral column, other less
frequently affected sites include the hip, knee, and
sacroiliac joints [3]. This review focuses on the accurate
diagnosis of TB by analysing the protein expression that is
dominant in the different phases of Mycobacterium tuber-
culosis infection. With the help of this approach, we can
easily distinguish between the active and latent phases of
TB infection in an individual.
Aetiopathogenesis
The major causes of the spread of EPTB are poverty,
overcrowding, malnutrition, repeated pregnancies in
women and HIV infection. More than 40 years after the
commencement of effective chemotherapy, TB sadly re-
mains the single largest infectious disease that causes
mortality, resulting in about 5 deaths/min [4]. To date, the
disease is not completely eradicated, because of its com-
plex pathogenesis. Primary infection with M. tuberculosis
rarely leads to disease. However, the infection is instead
typically controlled by the host’s immune system and most
of the viable bacilli are wiped out. Nevertheless, some are
still able to survive in the host body and remain inactive for
decades prior to reactivating to cause clinical disease again
(Figure 2) [5]. Approximately one-third of the entire pop-
ulation may be latently infected with dormant bacilli [6].
Latent TB means a patient is infected with M. tuberculosis,
but the patient does not have active TB. Active TB can be
transmissible whereas latent TB is not, and it is therefore
not possible to acquire TB from a person who is latently
infected with M. tuberculosis.
The main risk is that probably 10% of patients infected
with latent TB (5% in the first 2 years after the infection and66%
31%
3%
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Figure 1 Worldwide prevalence of tuberculosis cases.0.1% per year thereafter) will be more prone to develop
active TB. The human tubercular bacillus (M. tuberculosis)
is a causative agent for almost all types of osteoarticular
TB. Osteoarticular TB can affect the spine, hip and knee
joint, foot, elbow, wrist, hand, shoulder, and diaphysial
foci. The most common method of proliferation is through
the haematogenous route. It commonly proliferates to the
vertebral column through Batson’s prevertebral venous
plexus. The spread of infection is through the haematoge-
nous route (Figure 3).
Clinical manifestation
The most common form of osteoarticular TB is spinal TB. It
accounts for almost 50% of all osteoarticular TB cases [7]. In
most cases, the infection initially progresses gradually, and
only in rare cases is there an acute manifestation. The
common symptoms are weight loss, night sweats, fatigue,
and rise in temperature in the evening. Whenever the
infection occurs for a longer duration, occurrence of cold
abscess is noticed in the soft tissues, following its path
through the intermuscular planes. The distribution of spinal
TB is as follows: 42% thoracic involvement, 12% thor-
acolumbar, 26% lumbar, 12% cervical, 5% cervicodorsal, and
3% lumbosacral. It is the second most common skeletal
lesion occurring in any age group, but is frequently seen in
children. Initially, it appears with a painful hip limp. In
later stages, when destruction has been continuous, the
limb becomes tilted, abducted, and rotated internally, with
a noticeable shortening of the limb [8]. The different forms
of osteoarticular TB according to the site of lesions are as
follows: TB of the knee joint, ankle joint, foot, upper ex-
tremity, wrist, elbow, tuberculous osteomyelitis, TB of
small bones, TB of tendons, sheath, and bursae. Despite
ongoing efforts, effective global TB control is hampered by
the need for long-term chemotherapy, which leads to poor
patient compliance [9].
Disadvantage of current diagnostic methods of
osteoarticular TB
The diagnosis as well as treatment of extrapulmonary
tuberculosis (EPTB) remains a major problem until today. In
active pulmonary tuberculosis (PTB), clinical symptoms
confirmed by a laboratory test may give a relatively clear
result, whereas the diagnosis can be problematic in pa-
tients with EPTB, children, elderly, and immunosuppressed
individuals [10]. Radiographic analysis (X-rays) in EPTB is
often not conclusive, and the tuberculin purified protein
derivative skin test is considered unreliable by many clini-
cians. Bacteria in EPTB cases can be present in low numbers
at inaccessible sites. As a result, invasive procedures are
usually necessary to confirm the infection [10]. Further-
more, the HIV epidemic has changed the proportion of EPTB
among TB cases, pushing the number of new EPTB cases to
account for > 15% of the total TB cases [11].
Testing for active TB disease through antibodies or anti-
gens is found to be extremely difficult in blood. Patients can
have different antibody responses, which could suggest that
they have active TB even when they do not. Antibodies may
also develop against other organisms, which again could be a
Figure 2 Basic mechanism of infection of Mycobacterium tuberculosis.
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isms share the same antigens, making test results unreliable.
These factors can result in TB disease not being identified or
wrongly diagnosed. The WHO [12] report suggests that in theFigure 3 Diagrammatic representation of Mycobacterium
tuberculosis infection in skeletal system spread.evaluation of 94 studiesd67 for PTB and 27 for EPTB. Strong
evidence showed that the blood tests produced an unac-
ceptable level of wrong resultsdfalse-positives or false-
negativesdrelative to the tests endorsed by WHO. The
research revealed “low sensitivity” in commercial blood
tests which leads to an unacceptably high number of pa-
tients being wrongly given the “all clear” (i.e., a false-
negative when in reality they have active TB). This can
result in the transmission of the disease or even death from
untreated TB. It also revealed “low specificity” that led to
an unfortunately high number of patients being wrongly
diagnosed with TB (i.e., a false-positive when in reality they
do not have active TB). However, patients’ decision to un-
dergo unnecessary treatment, while the real cause of their
illness remains undiagnosed, may further lead to premature
death. More than 1 million people worldwide are mis-
diagnosed with TB, although in reality they have an incur-
able disease with a similar outlook to many cancers. More
than a million of these false diagnostic tests are carried out
annually to diagnose active TB, often at a substantial cost to
patients [12].
Osteoarticular TB accounts for about 1e3% of all TB
cases and is one of the major causes of osteomyelitis [13].
Although any bone, joint, or bursa can be infected, the
spine, hip, and knee are the preferred sites of infection,
representing 70e80% of infections [14,15]. TB of the spine,
if not diagnosed properly and treated adequately, may lead
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accurate diagnosis of osteoarticular TB poses difficulty
owing to deep inaccessible lesions and initiation of empir-
ical antitubercular therapy (ATT) in the majority of cases
[17]. For the most part, the diagnosis of osteoarticular TB is
based on clinical suspicion and imaging findings, particu-
larly in endemic regions [14]. Recently, Sharma et al [18]
introduced a highly sensitive and specific multiplex poly-
merase chain reaction (PCR) targeting IS6110 and MPB-64
protein genes in the longitudinal evaluation of synovial
fluid and pus samples from 80 cases of osteoarticular TB
[18].
Clinical diagnostics
The traditional methods fail in early diagnosis of the dis-
ease (Table 1) [19e26]. Staining for acid-fast bacilli and
culturing of M. tuberculosis have low sensitivity and spec-
ificity [27]. In imaging, by the time the disease becomes
apparent on X-rays, the patient has already reached the
advanced stage of the disease [28]. Magnetic resonance
imaging is more sensitive than X-rays but lacks pathogno-
monic findings that differentiate TB from other spinal in-
fections or possibly a neoplasm [23,29]. The evaluation of
the 16-kDa antigen as a serodiagnostic tool in PTB and EPTB
patients has been done earlier. Serodiagnostic tests for TB
have always had drawbacks of suboptimal sensitivity and
specificity. A previous study showed that the antigen used
gave encouraging results in PTB only, whereas in EPTB, it
had a limited impact in terms of sensitivity [30].
Molecular diagnosis
A major breakthrough in the diagnosis of EPTB is highly
associated with the HIVeEPTB coinfection, detected by
nucleic acid amplification tests such as PCR to detect
nucleotide sequences unique to M. tuberculosis directly in
extrapulmonary specimens, offering better accuracy than
acid-fast bacilli smear microscopy and greater speed than
culture [31e34].
The exposure of M. tuberculosis to nitric oxide donors
accelerated the production of alpha-crystallin (acr), thusTable 1 Various diagnostic techniques for detecting Mycobacte
Diagnostic methods Disadvantages
DNA-PCR DNA-PCR is unable to differentiate
and nonviable organisms.
CSP-Ag’s ELISA Could not recognise latent infectio
Culturing of M. tuberculosis Time-consuming; took nearly 6e8 w
less sensitive.
MRI (Pott’s spine) There is no pathognomonic finding
tuberculosis from other infections.
Purified protein test Because of its highly cross-reactive
reliable results in areas where ther
load of nontuberculous mycobacte
Acid-fast bacilli (AFB) Low specific results.
ELISA Z enzyme-linked immunosorbent assay; MRI Z magnetic resonresembling the conditions induced by the immune response
[35]. The presence of this protein was associated with
increased thickness of bacterial cell wall, which is charac-
teristic of bacteria under stressful conditions [36], and to
other specific stressful conditions for M. tuberculosis, such
as treatment with antibiotics (e.g., rifampicin or strepto-
mycin) [37]. This increased production also leads to a
higher expression of the sigma factor F (sigF), a s-subunit
of the RNA polymerase that is stimulated under stress. To
understand the mechanisms associated with the metabolic
changes that may lead to the induction of latent bacilli, the
sigma factor proves to be a strong link [38]. With the real-
time PCR system, expression of acr was studied in vitro
unstirred culture, allowing a progressive limited O2 con-
centration; the induction of stressed bacilli by decreasing
pH and using two types of bacilli (i.e., from cultures in an
exponential and a stationary phase), to establish a paral-
lelism between bacilli in the latent and active phases in a
murine model of TB was also studied. As a result, the
expression of acr has been closely related to latency, and
thus could be a valuable marker [37]. The expression of acr
was maintained even when the levels of 16S rRNA were
undetectable after a long-term chemotherapy. Therefore,
this was the best value for detecting the expression of
latent bacilli with the real-time PCR methodology used. In
conclusion, data from experimental in vitro stressing pro-
cess with progressive low oxygen levels and decreasing pH
values have supported the search for a useful marker
monitoring latent bacilli in a murine model of TB. There-
fore, the expression of acr may be a new tool for monitoring
this population and contribute to its eradication in the
future [39]. On the contrary, the early secreted antigenic
target-6 and culture filtrate 10 protein (CFP-10), which act
as virulence factors in M. tuberculosis, are secreted by the
ESX-1 system into the host cell and thereby contribute to
pathogenicity. T cell responses to early-secreted antigenic
target 6-kDa protein (ESAT-6) and the newly identified CFP-
10, both of which are particularly expressed by M. tuber-
culosis but not by bacillus CalmetteeGue´rin (BCG) strains,
were studied. In the study, most patients with active or
treated TB responded to the specific antigens ESAT-6, CFP-
10 or both. In vitro T cell responses to ESAT-6 and CFP-10
appear to be highly sensitive and specific for therium tuberculosis.
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Figure 4 Hypervirulent gene dosR, which activates hspX with
many other genes (activation of hspX w80-fold). This hspX
encodes alpha-crystallin (acr) protein, which is a major anti-
gen. The acr is responsible for the long-term survival of the
bacteria.
22 N. Rizvi et al.detection of infection with M. tuberculosis and to be
significantly more discriminative than responses to the
complex antigens, especially in BCG-vaccinated individuals.
ESAT-6 and CFP-10 are therefore considered highly prom-
ising antigens which will be included in future studies
aimed at specific immunodiagnosis of TB [40]. The DNA-PCR
is unable to differentiate between viable and nonviable
organisms, whereas bacterial mRNA with a mean half-life of
3e5 minutes is more prone to degradation than genomic
DNA; thus, a positive mRNA signal would indicate the
presence of viable organisms [19]. The mRNA-based reverse
transcriptase-PCR (RT-PCR) is a rapid method used to
differentiate viable from nonviable M. tuberculosis and has
also been used for the diagnosis of EPTB as well as to
monitor drug resistance [19,41].
Protein expressed in osteoarticular TB
In this review, we discuss a protein that is responsible for
the long-term survival of M. tuberculosis in the stationary
phase and those proteins that act as virulence factors of M.
tuberculosis.
Some bacteria form spores when under stress. They have
a genetic programme, triggered by hypoxia and respiratory
poisons and controlled by the transcription factor DosR
[42]. This transcription factor regulates the development of
a latently growing form without morphological differenti-
ation. This quiescent (latent) physiological state maintains
viability for a longer period and, importantly, shows
phenotypic (as opposed to genetic) drug resistance.
Therefore, it is thought that this stage of the bacillus life
cycle contributes to both key issues faced in the control of
TB, the symptom-free latent state of TB infection and the
persistence of active disease despite prolonged chemo-
therapy [43e45].
It now appears that hypervirulent mutants of M. tuber-
culosis, with higher growth rates in vivo, have mutations in
both regulatory and structural genes. DosR (devR, Rv2031c)
is a hypervirulent gene that activates the transcription of
about 50 genes of M. tuberculosis in response to hypoxia
and nitric oxide stress. The most significant activation
(w80-fold) of the hspX (acr, Rv2031c) gene encodes a 16-
kDa acr-like protein, a major antigen (Figure 4) [46].
Although the 16-kDa acr homologue of M. tuberculosis is
the most dominant protein produced by stationary-phase
cultures in vitro, it is unrecognisable in exponentially
growing cultures [47]. Other proteins which we are going to
study, ESAT-6 and CFP-10, have been mentioned as domi-
nant antigens recognised by T cells and are considered
virulence factors in M. tuberculosis [48].
Role of acr, ESAT-6, and CFP-10 for accurate
diagnosis of osteoarticular TB
acr
Oxygen tension is one of the major factors frequently
associated with the establishment and maintenance of
latent TB [44]. In vivo, the bacilli number in a lesion
commonly correlates well with the degree of oxygenation[49]. Hypoxia is predicted to be a key host-induced stress
limiting the growth of the pathogen in vivo. However,
various studies in vitro and in vivo indicate that M.
tuberculosis adapts to oxygen limitation by entering into a
metabolically altered state while awaiting the opportunity
to reactivate [50]. Replication of M. tuberculosis requires
O2, but bacteria have a phenomenal ability to survive for
years without O2 in vitro [49]. M. tuberculosis is main-
tained under anaerobic conditions in vitro and therefore
loses its acid-fast characteristics [51,52]. Wayne and col-
leagues [53,54] have pioneered the use of hypoxic culture
conditions to generate nonreplicating persistent bacilli
in vitro as a model for latency. Variants of this model have
been used to identify M. tuberculosis genes that are
potentially important for the development or mainte-
nance of the latent state [47,55]. One such gene is acr
(also known as hspX, Rv2031), which encodes acr. The M.
tuberculosis acr is a dominant antigen in vivo, recognised
by most M. tuberculosis patient sera [56]. The acr is a
member of the small heat shock protein family that forms
high-molecular-weight aggregates and has chaperone ac-
tivity in vitro [57]. Under hypoxic conditions, acr expres-
sion is rapidly increased significantly [47,58]. The 16-kDa
protein, a-crystallin homologue [56] encoded by the hspX
gene [59] is synthesised at a low level in logarithmic-phase
cultures, but increases remarkably while in transition from
the log phase to the stationary phase. This protein be-
comes one of the most abundant proteins in stationary-
phase bacteria that is vital for the survival of stationary-
phase bacteria [57].
Belay et al [60] reported on the dynamics of proin-
flammatory [interferon (IFN)-g, tumour necrosis factor
(TNF)-a)] and anti-inflammatory [interleukin (IL)-10] cyto-
kines against Rv2031 (acr), using whole blood assay in
human cohorts in a TB endemic setting. The levels of IFN-g,
TNF-a, and IL-10 against Rv2031 were found to be highest
during latent TB infection; this may indicate their potential
as markers of defence against TB. The findings of their
study suggest the potential of IFN-g, TNF-a, and IL-10
against Rv2031 (acr) as biomarkers of the host response to
M. tuberculosis during convalescence from, and the
absence of, active TB [60].
This protein was also investigated in some animal
models; for example, adjunctive immunotherapy of mice
Novel proteins as biomarkers for osteoarticular TB 23with a DNA vaccine expressing Rv2031(acr) was shown to
significantly reduce bacillary load, shorten treatment
duration, result in complete restoration of lung architec-
ture and prevent reactivation [61]. Likewise, in guinea pigs,
Rv2031-based vaccination was shown to impart protection
against TB through enhanced production of IL-12, IL-10, and
TGF-b [62].
ESAT-6 and CFP-10
ESAT-6 and CFP-10 have been mentioned as dominant an-
tigens recognised by T cells and are considered virulence
factors in M. tuberculosis [48]. Previous studies have shown
that these two proteins can induce a strong T cell-mediated
immune response, are apparently involved in membrane
and/or host-cell lysis, and are key virulence factors
secreted by M. tuberculosis [63].
ESAT-6 is a potent T-cell protein antigen synthesised by
M. tuberculosis [64]. CFP-10 is a protein that is encoded by
the esxB gene. CFP-10 is a 10-kDa secreted antigen from M.
tuberculosis. It forms a 1:1 heterodimeric complex with
ESAT-6. Both genes are expressed from the region of dif-
ference 1 (RD1) of the bacterial genome and play a key role
in the virulence of the infection [65]. ESAT-6 or esxA and
CFP-10 or esxB genes are located in RD1 (Figure 5). The
ESAT-6/CFP-10 complex is secreted by the ESX-1 secretion
system, also known as the RD1 region. In the RD1 locus, the
esx genes are part of a conserved segment encoding
members of five additional protein families [66]. These two
have been described as dominant antigens recognised by T
cells and are considered virulence factors in M. tubercu-
losis [67]. In the later stages of infection, these two pro-
teins play a vital role in assisting in the translocation of M.
tuberculosis from the phagosome into the cytoplasm of the
host cell [68].
CFP-10 and ESAT-6 are encoded in RD1. The importance
of ESX-1 proteins for pathogenicity was shown via the
reintroduction of the extended RD1 region into BCG [69],Figure 5 Diagrammatic representation of esxA and esxB
genes, which encode ESAT6 and CFP-10, respectively. The
latter forms a heterodimeric complex which acts as a virulence
factor in Mycobacterium tuberculosis infection. CFP-
10 Z culture filtrate protein 10; ESAT6 Z early-secreted
antigenic target 6-kDa protein.deletion of RD1 from M. tuberculosis [70], signature tag-
ged and insertional mutagenesis [71,72] and deletions of
targeted gene [73e75]. Several effects attributed to
pathogenicity have occurred and are associated with the
expression of ESX-1 in M. tuberculosis and/or M. mar-
inum, a fish pathogen that harbours an ESX-1 system
similar to that of M. tuberculosis [76]. These include
suppression of proinflammatory responses [77], interac-
tion with Toll-like receptor 2 [78] and/or syntenin [79],
cytotoxicity and/or cytolysis [80], necrosis [81], phag-
osome maturation arrest [82], and formation of granuloma
[83].
In the study conducted by Borgstrom et al [84], Th1
proinflammatory cytokines were expressed at high levels
with both CFP-10 and ESAT-6 stimulation in samples from
patients with microbiologically/histopathologically verified
active TB, and the results correlated very well with pro-
liferative responses [84].
Yuan et al [85] evaluated the value of ESAT-6/CFP-10
fusion protein using the enzyme-linked immunospot
(ELlSPOT) assay for the diagnosis of spinal TB. As a result,
with high sensitivity and specificity, the ELISPOT assay
using CFP-10/ESAT6 fusion protein as antigen proved to
be an effective technique for auxiliary diagnosis of spinal
TB [85].
In another study performed by Belay et al [60], a positive
and significant correlation between Rv2031 (acr) and ESAT-
6 CFP-10 specific cytokine responses in each study group
was reported. From previous studies on the three proteins
(acr, ESAT-6, and CFP-10) of M. tuberculosis, we have come
to the conclusion that acr is responsible for the bacterial
growth survival when the microbe is in stationary/latent
phase, whereas the other two proteins (i.e., ESAT-6 and
CFP-10) act as virulence factors, which means the active
phase of the disease.
Conclusion and perspectives
Misdiagnosis of TB extracts a huge toll on patients both in
terms of health and wealth. For correct and sensitive
diagnosis, we need to cope up with the drawbacks of the TB
diagnostic techniques. For treatment of any disease, ac-
curate diagnosis is essential; however, a wrongly diagnosed
disease may cost the patient’s life. Using the expression of
a-crystallin, ESAT-6, and CFP-10 proteins of MTB to differ-
entiate between latent and active MTB infection among
different individuals may help overcome these problems.
Moreover, target populations can be more specifically
identified, which can help in wise decision making and
logical prescription. Patient morbidity can also be reduced.
Accurate diagnosis will also help prevent the development
of antibiotic-resistant strains (which develop because of
the empirical and generous use of these drugs viz., ATT)
and consequent development of multidrug-resistant TB,
which in itself represents a bigger challenge. Accurate
diagnosis of active TB can help us formulate new specific
treatment guidelines.
Conflicts of interest
The authors have no conflicts of interest to declare.
24 N. Rizvi et al.References
[1] World Health Organization. Global tuberculosis control 2014.
Geneva, Switzerland: World Health Organization; 2014. www.
who.int/tb/publications/global_report/.
[2] Teo HE, Peh WC. Skeletal tuberculosis in children. Pediatr
Radiol 2004;34:853e60.
[3] Moore SL, Rafii M. Imaging of musculoskeletal and spinal
tuberculosis. Radiol Clin North Am 2001;39:329e42.
[4] Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis inci-
dence and mortality during 1990e2000. Bull WHO 1994;72:
213e20.
[5] Wayne LG. Dormancy of Mycobacterium tuberculosis and la-
tency of disease. Eur J Clin Microbiol Infect Dis 1994;13:
908e14.
[6] World Health Organization. Global tuberculosis control: sur-
veillance, planning, financing. Geneva, Switzerland: World
Health Organization; 2009.
[7] Martini M, editor. Tuberculosis of the bones and joints. Hei-
delberg: Springer-Verlag; 1988.
[8] Sankaran B. Tuberculosis of bones and joints. Ind J Tub 1993;
40:109e18.
[9] Hu Y, Liu A, Menendez MC, Garcia MJ, Oravcova K,
Gillespie SH, et al. HspX knock-out in Mycobacterium tuber-
culosis leads to shorter antibiotic treatment and lower relapse
rate in a mouse modelda potential novel therapeutic target.
Tuberc (Edinb) 2015;95:31e6.
[10] Munk ME, Arend SM, Brock I, Ottenhoff TH, Andersen P. Use of
ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary
tuberculosis. J Infect Dis 2001;183:175e6.
[11] Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE,
Hopewell PC. Treatment of tuberculosis in patients with
advanced human immunodeficiency virus infection. N Engl J
Med 1991;324:289e94.
[12] World Health Organization. WHO warns against the use of
inaccurate blood tests for active tuberculosis. Geneva,
Switzerland: World Health Organization; 2011. Available at:
http://www.who.int/mediacentre/news/releases/2011/tb_
20110720/en/ [accessed 14.01.16].
[13] Sun YS, Lou SQ, Wen JM, Lv WX, Jiao CG, Yang SM, et al.
Clinical value of polymerase chain reaction in the diagnosis of
joint tuberculosis by detecting the DNA of Mycobacterium
tuberculosis. Orthop Surg 2011;3:64e71.
[14] Pandey V, Chawla K, Acharya K, Rao S, Rao S. The role of
polymerase chain reaction in the management of osteo-
articular tuberculosis. Int Orthop 2009;33:801e5.
[15] Singh A, Jain G, Kumar V. Tuberculosis of sacroiliac joint e a
rare musculoskeletal presentation of tuberculosis. J Bone Jt
Dis 2011;26:38e40.
[16] Jain AK, Jena SK, Singh MP, Dhammi IK, Ramachadran VG,
Dev G. Evaluation of clinico-radiological, bacteriological,
serological, molecular and histological diagnosis of osteo-
articular tuberculosis. Indian J Orthop 2008;42:173e7.
[17] Vardhan V, Yanamandra U. Diagnosis of osteoarticular tuber-
culosis. Indian J Rheumatol 2011;6:87e94.
[18] Sharma K, Sharma A, Sharma SK, Sen RK, Dhillon MS,
Sharma M. Does multiplex polymerase chain reaction in-
crease the diagnostic percentage in osteoarticular tubercu-
losis. A prospective evaluation of 80 cases. Int Orthop 2011;
36:255e9.
[19] Rana T, Singh UB, Kulshrestha V, Kaushik A, Porwal C,
Agarwal N, et al. A Utility of reverse transcriptase PCR and
DNA-PCR in the diagnosis of female genital tuberculosis. J Med
Microbiol 2011;60:486e91.
[20] Tiwari D, Tiwari RP, Chandra RP, Bisen S, Haque S. Efficient
ELISA for diagnosis of active tuberculosis employing a cocktailof secretory proteins of Mycobacterium tuberculosis. Folia
Biol 2014;60:10e20.
[21] Cheng VC, Yam WC, Hung IF, Woo PC, Lau SK, Tang BS,
et al. Clinical evaluation of the polymerase chain reaction
for the rapid diagnosis of tuberculosis. J Clin Pathol 2004;
57:281e5.
[22] Griffith JF, Kumta SM, Leung PC, Cheng JC, Chow LT,
Metreweli C. Imaging of musculoskeletal tuberculosis: a new
look at an old disease. Clin Orthop Relat Res 2002;398:32e9.
[23] Bass Jr JB. The tuberculin test. In: Reichmann LB,
Hershfield ES, editors. Tuberculosis: a comprehensive interna-
tional approach. New York: Marcel Dekker; 1993. p. 139e48.
[24] Bates JH. The tuberculin skin test and preventive treatment
for tuberculosis. In: Rom WM, Garay S, editors. Tuberculosis.
Boston: Little, Brown; 1996. p. 865e72.
[25] Kramer N, Rosenstein ED. Rheumatologic manifestations of
tuberculosis. Bull Rheum Dis 1997;46:5e8.
[26] Van der Spoel van Dijk A, MCleod A, Botha PL, Shipley JA,
Kapnoudhis MA, Beukes CA. The diagnosis of skeletal tuber-
culosis by polymerase chain reaction. Cent Afr J Med 2000;46:
144e9.
[27] Singh A, Verma V, Wali S, Srivastava RN. Tubercular tenosyn-
ovitis of extensor tendons of foot e a rare presentation of
musculoskeletal tuberculosis in an infant. Internet J Med
Updat 2012;7:45e7.
[28] Garg RK, Somvanshi DS. Spinal tuberculosis. J Spinal Cord Med
2011;34:440e54.
[29] Bell GR, Stearns KL, Bonutti PM, Boumphrey FR. MRI diagnosis
of tuberculous vertebral osteomyelitis. Spine (Phila Pa 1976)
1990;15:462e548.
[30] Kaushik A, Singh UB, Porwal C, Venugopal SJ, Mohan A,
Krishnan A, et al. Diagnostic potential of 16 kDa (HspX, a-
crystalline) antigen for serodiagnosis of tuberculosis. JN In-
dian J Med Res 2012;135:771e7.
[31] Katoch VM. Newer diagnostic techniques for tuberculosis. In-
dian J Med Res 2004;120:418e28.
[32] Jacob JT, Nguyen TM, Ray SM. Male genital tuberculosis.
Lancet Infect Dis 2008;8:335e42.
[33] Abbara A, Davidson RN. Etiology and management of genito-
urinary tuberculosis. Nat Rev Urol 2011;8:678e88.
[34] Haldar S, Bose M, Chakrabarti P, Daginawala HF, Harinath BC,
Kashyap RS, et al. Improved laboratory diagnosis of tuber-
culosisdthe Indian experience. Tuberc (Edinb) 2011;91:
414e26.
[35] Garbe TR, Hibler NS, Deretic V. Response to reactive nitrogen
intermediates in Mycobacterium tuberculosis: induction of
the16-kilodalton a-crystallin homolog by exposure to nitric
oxide donors. Infect Immun 1999;67:460e5.
[36] Mason CA, Egli T. Dynamics of microbial growth in the decel-
erating and stationary phase of batch culture. In: Kjelleberg S,
editor. Starvation in bacteria. New York: Plenum Press; 1993.
p. 81e102.
[37] Michele TM, Chiew K, Bishai WR. Exposure to antibiotics
induces expression of the Mycobacterium tuberculosis
sigF gene: implications for chemotherapy against myco-
bacterial persistors. Antimicrob Agents Chem 1999;43:
218e25.
[38] Manganelli R, Dubanu E, Tyagi S, Kramer FR, Smith I. Differ-
ential expression of 10 sigma factor genes in Mycobacterium
tuberculosis. Mol Microbiol 1999;31:715e24.
[39] Gordillo S, Guirado E, Gil O, Dı´az J, Amat I, Molinos S, et al.
Usefulness of acr expression for monitoring latent Mycobac-
terium tuberculosis bacilli in ’in vitro’ and ’in vivo’ experi-
mental models. Scand J Immunol 2006;64:30e9.
[40] Sandra S, Arend M, Andersen P, van Meijgaarden KE,
Skjøt RLV, Subronto YW, et al. Detection of active
Novel proteins as biomarkers for osteoarticular TB 25tuberculosis infection by T cell responses to early-secreted
antigenic target 6-kDa protein and culture filtrate protein
10. J Infect Dis 2000;181:1850e4.
[41] Eltringham IJ, Drobniewski FA, Mangan JA, Butcher PD,
Wilson SM. Evaluation of reverse transcription-PCR and a
bacteriophage-based assay for rapid phenotypic detection of
rifampin resistance in clinical isolates of Mycobacterium
tuberculosis. J Clin Microbiol 1999;37:3524e7.
[42] Boon C, Dick T. Mycobacterium bovis BCG response regulator
essential for hypoxic dormancy. J Bacteriol 2002;184:6760e7.
[43] Wayne LG, Sohaskey CD. Non-replicating persistence of
Mycobacterium tuberculosis. Annu Rev Microbiol 2001;55:
139e63.
[44] Wayne LG, Hayes LG. An in vitro model for sequential study of
shift down of Mycobacterium tuberculosis through two stages
of nonreplicating persistence. Infect Immun 1996;64:2062e9.
[45] Barry 3rd CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J,
et al. The spectrum of latent tuberculosis: rethinking the
biology and intervention strategies. Nat Rev Microbiol 2009;7:
845e55.
[46] Hu Y, Movahedzadeh F, Stoker NG, Coates AR. Deletion of the
Mycobacterium tuberculosis alpha-crystallin-like hspX gene
causes increased bacterial growth in vivo. Infect Immun 2006;
74:861e8.
[47] Yuan Y, Crane DD, Simpson RM, Zhu Y, Hickey MJ,
Sherman III DR. The 16-kDa a-crystallin (Acr) protein of
Mycobacterium tuberculosis is required for growth in macro-
phages. Proc Nat Acad Sci U S A 1998;95:9578e83.
[48] Mahmoudi S, Mamishi S, Ghazi M, Sadeghi HR, Pourakbari B.
ESAT-6 (6-kDa early secretory antigenic target) and CFP-10
(10-kDa culture filtrate protein) have been described as
dominant antigens recognized by T-cells and considered as
virulence factors in Mycobacterium tuberculosis. Iran J
Microbiol 2013;5:374e8.
[49] Canetti G. Growth of the tubercle bacillus in the tuberculosis
lesion. In: The tubercle bacillus in the pulmonary lesion of
man. New York: Springer; 1955. p. 111e26.
[50] Yeager HJ, Azumi N, Underhill CB. Fibrosis: the formation of
the granuloma matrix. In: Rom WN, Garay SM, editors.
Tuberculosis. Boston: Little, Brown; 1996. p. 363e72.
[51] Gillespie J, Barton LL, Rypka E. Phenotypic changes in
mycobacteria grown in oxygen-limited conditions. J Med
Microbiol 1986;21:251e5.
[52] Parish T, Stoker NG. Use of a flexible cassette method to
generate a double unmarked Mycobacterium tuberculosis
tlyAplcABC mutant by gene replacement. Microbiology 2000;
146:1969e75.
[53] Wayne LG, Diaz GA. Autolysis and secondary growth of
Mycobacterium tuberculosis in submerged culture. J Bacteriol
1967;93:1374e81.
[54] Wayne LG, Sramek HA. Metronidazole is bactericidal to
dormant cells of Mycobacterium tuberculosis. Antimicrob
Agents Chemother 1994;38:2054e8.
[55] Lim A, Eleuterio M, Hutter B, Murugasu-Oei B, Dick T. Oxygen
depletion-induced dormancy in Mycobacterium bovis BCG. J
Bacteriol 1999;181:2252e6.
[56] Verbon A, Hartskeerl RA, Schuitema A, Kolk AH, Young DB,
Lathigra R. The 14,000-molecular-weight antigen of Myco-
bacterium tuberculosis is related to the alpha-crystallin
family of low-molecular-weight heat shock proteins. J Bac-
teriol 1992;174:1352e9.
[57] Yuan Y, Crane DD, Barry III CE. Stationary phase-associated
protein expression in Mycobacterium tuberculosis: function
of the mycobacterial alpha-crystallin homolog. J Bacteriol
1996;178:4484e92.
[58] Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI,
Schoolnik GK. Regulation of the Mycobacterium tuberculosishypoxic response gene encoding alpha-crystallin. Proc Natl
Acad Sci U S A 2001;98:7534e9.
[59] Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D,
et al. Deciphering the biology of Mycobacterium tuberculosis
from the complete genome sequence. Nature 1998;393:
537e44.
[60] Belay M, Legesse M, Mihret A, Bekele Y, Ottenhoff THM,
Franken KLMC, et al. Pro- and anti-inflammatory cytokines
against Rv2031 are elevated during latent tuberculosis: a
study in cohorts of tuberculosis patients, Household Contacts
and Community Controls in an Endemic Setting. PLoS One
2015;10:e0124134.
[61] Chauhan P, Jain R, Dey B, Tyagi AK. Adjunctive immuno-
therapy with alpha-crystallin based DNA vaccination reduces
tuberculosis chemotherapy period in chronically infected
mice. Sci Rep 2013;3:1821.
[62] Dey B, Jain R, Khera A, Gupta UD, Katoch VM, Ramanathan VD,
et al. Latency antigen alpha-crystallin based vaccination im-
parts a robust protection against TB by modulating the dy-
namics of pulmonary cytokines. PLoS One 2011;6:e18773.
[63] Waters WR, Nonnecke BJ, Palmer MV, Robbe-Austermann S,
Bannantine JP, Stabel JR, et al. Use of recombinant ESAT-6:
CFP-10 fusion protein for differentiation of infections of cat-
tle by Mycobacterium bovis and by M. avium subsp. avium and
M. avium subsp. paratuberculosis. Clin Diagn Lab Immunol
2004;11:729e35.
[64] Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P,
Gicquel B. A Mycobacterium tuberculosis operon encoding
ESAT-6 and a novel low-molecular-mass culture filtrate pro-
tein (CFP-10). Microbiology 1998;144:3195e203.
[65] Meher AK, Bal NC, Chary KV, Arora A. Mycobacterium tuber-
culosis H37Rv ESAT-6-CFP-10 complex formation confers
thermodynamic and biochemical stability. FEBS J 2006;273:
1445e62.
[66] Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A,
et al. Recombinant BCG exporting ESAT-6 confers enhanced
protection against tuberculosis. Nat Med 2003;9:533e9.
[67] Forrellad MA, Klepp LI, Gioffre´ A, Sabio Y, Garcı´a J,
Morbidoni HR, et al. Virulence factors of the Mycobacterium
tuberculosis complex. Virulence 2012;17:43e66.
[68] Van der Wel N, Hava D, Houben D, Fluitsma D, van Zon M,
Pierson J, et al. M. tuberculosis and M. leprae translocate
from the phagolysosome to the cytosol in myeloid cells. Cell
2007;129:1287e98.
[69] Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1
contributed to the attenuation of the live tuberculosis vac-
cines Mycobacterium bovis BCG and Mycobacterium microti.
Mol Microbiol 2002;46:709e17.
[70] Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA,
et al. Deletion of RD1 from Mycobacterium tuberculosis
mimics bacilli CalmetteeGuerin attenuation. J Infect Dis
2003;187:117e23.
[71] Collins DM, Skou B, White S, Bassett S, Collins L, For R, et al.
Generation of attenuated Mycobacterium bovis strains by
signature-tagged mutagenesis for discovery of novel vaccine
candidates. Infect Immun 2005;73:2379e86.
[72] Sassetti CM, Rubin EJ. Genetic requirements for mycobacte-
rial survival during infection. Proc Natl Acad Sci U S A 2003;
100:12989e94.
[73] Brodin P, Majlessi L, Marsollier L, de Jonge MI, Bottai D,
Demangel C, et al. Dissection of ESAT-6 system 1 of Myco-
bacterium tuberculosis and impact on immunogenicity and
virulence. Infect Immun 2006;74:88e98.
[74] Guinn KI, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE,
Lewinsohn DM, et al. Individual RD1-region genes are required
for export of ESAT-6/CFP-10 and for virulence of Mycobacte-
rium tuberculosis. Mol Microbiol 2004;51:359e70.
26 N. Rizvi et al.[75] Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM,
et al. The primary mechanism of attenuation of bacillus
CalmetteeGuerin is a loss of secreted lytic function required
for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A
2003;100:12420e5.
[76] Marmiesse M, Brodin P, Buchrieser C, Gutierrez C, Simoes N,
Vincent V, et al. Macro-array and bioinformatics analyses
reveal mycobacterial ‘core’ genes, variation in the ESAT-6
gene family and new phylogenetic markers for the Mycobac-
terium tuberculosis complex. Microbiology 2004;150:483e96.
[77] Stanley SA, Raghavan S, Hwang WW, Cox JS. Acute infection
and macrophage subversion by Mycobacterium tuberculosis
require a specialized secretion system. Proc Natl Acad Sci U S
A 2003;100:13001e6.
[78] Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S,
Bhattacharyya A, et al. Direct extracellular interaction be-
tween the early secreted antigen ESAT-6 of Mycobacterium
tuberculosis and TLR2 inhibits TLR signalling in macrophages.
Nat Immunol 2007;8:610e8.
[79] Schumann G, Schleier S, Rosenkrands I, Nehmann N, Halbich S,
Zipfel PF, et al. Mycobacterium tuberculosis secreted protein
ESAT-6 interacts with the human protein syntenin-1. Cent Eur
J Biol 2006;1:183e202.
[80] Gao LY, Guo S, McLaughlin B, Morisaki H, Engel JN, Brown EJ. A
mycobacterial virulence gene cluster extending RD1 isrequired for cytolysis, bacterial spreading and ESAT-6 secre-
tion. Mol Microbiol 2004;53:1677e93.
[81] Junqueira-Kipnis AP, Basaraba RJ, Gruppo V, Palanisamy G,
Turner OC, Hsu T, et al. Mycobacteria lacking the RD1 region
do not induce necrosis in the lungs of mice lacking interferon-
gamma. Immunology 2006;119:224e31.
[82] Tan T, Lee W, Alexander DC, Grinstein S, Liu J. The ESAT-
6/CFP-10 secretion system of Mycobacterium marinum
modulates phagosome maturation. Cell Microbiol 2006;8:
1417e29.
[83] Volkman HE, Clay H, Beery D, Chang JC, Sherman DR,
Ramakrishnan L. Tuberculous granuloma formation is
enhanced by a mycobacterium virulence determinant. PLoS
Biol 2004;2:e367.
[84] Borgstrom E, Andersen P, Atterfelt F, Julander I, Ka¨llenius G,
Maeurer M, et al. Immune responses to ESAT-6 and CFP-10 by
FASCIA and multiplex technology for diagnosis of M. tuber-
culosis infection; IP-10 is a promising marker. PLoS One 2012;
7:e43438.
[85] Yuan K, Liang D, Wu XQ, Yao ZS, Jin DX, Yang ZD, et al.
Diagnostic value of enzyme-linked immunospot assay using
CFP10/ESAT6 fusion protein as antigen in spinal tubercu-
losis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2015;37:
44e9.
